 Monika Fleshner
Concepts (681)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stress, Psychological | 57 | 2017 | 1044 | 7.810 |
Why?
| | Stress, Physiological | 45 | 2019 | 429 | 7.260 |
Why?
| | Physical Conditioning, Animal | 21 | 2019 | 209 | 4.420 |
Why?
| | Rats, Inbred F344 | 45 | 2019 | 244 | 3.480 |
Why?
| | Rats | 130 | 2021 | 5517 | 3.340 |
Why?
| | Prebiotics | 6 | 2021 | 24 | 3.290 |
Why?
| | HSP72 Heat-Shock Proteins | 15 | 2014 | 29 | 3.240 |
Why?
| | Helplessness, Learned | 13 | 2016 | 64 | 3.130 |
Why?
| | Motor Activity | 25 | 2019 | 689 | 3.010 |
Why?
| | Corticosterone | 37 | 2016 | 257 | 2.290 |
Why?
| | Running | 14 | 2016 | 238 | 2.290 |
Why?
| | Brain | 25 | 2019 | 2639 | 2.080 |
Why?
| | Animals | 155 | 2021 | 34345 | 1.790 |
Why?
| | Fear | 17 | 2015 | 318 | 1.590 |
Why?
| | Cytokines | 15 | 2016 | 1927 | 1.520 |
Why?
| | Circadian Rhythm | 7 | 2021 | 420 | 1.510 |
Why?
| | Exosomes | 5 | 2017 | 92 | 1.460 |
Why?
| | Electroshock | 26 | 2015 | 151 | 1.450 |
Why?
| | Escherichia coli Infections | 7 | 2012 | 110 | 1.370 |
Why?
| | Immune System | 8 | 2017 | 183 | 1.340 |
Why?
| | Rats, Sprague-Dawley | 67 | 2021 | 2512 | 1.330 |
Why?
| | Interleukin-1beta | 6 | 2016 | 382 | 1.330 |
Why?
| | Heat-Shock Proteins | 7 | 2006 | 129 | 1.270 |
Why?
| | Hemocyanins | 17 | 2008 | 57 | 1.250 |
Why?
| | Inflammasomes | 3 | 2016 | 120 | 1.240 |
Why?
| | Corpus Striatum | 7 | 2017 | 147 | 1.240 |
Why?
| | Immunity, Innate | 9 | 2014 | 759 | 1.240 |
Why?
| | Anxiety | 10 | 2018 | 924 | 1.220 |
Why?
| | Gastrointestinal Tract | 3 | 2016 | 175 | 1.210 |
Why?
| | Proto-Oncogene Proteins c-fos | 11 | 2019 | 199 | 1.200 |
Why?
| | Inflammation | 10 | 2016 | 2612 | 1.190 |
Why?
| | Exercise | 15 | 2016 | 1779 | 1.180 |
Why?
| | Physical Exertion | 6 | 2012 | 236 | 1.180 |
Why?
| | Lactoferrin | 2 | 2018 | 29 | 1.160 |
Why?
| | Spleen | 12 | 2013 | 513 | 1.130 |
Why?
| | Bacteria | 6 | 2020 | 767 | 1.130 |
Why?
| | Neuronal Plasticity | 12 | 2018 | 226 | 1.100 |
Why?
| | Serotonin | 10 | 2019 | 328 | 1.090 |
Why?
| | Male | 137 | 2021 | 60792 | 1.080 |
Why?
| | Amygdala | 7 | 2017 | 184 | 0.970 |
Why?
| | Sympathetic Nervous System | 4 | 2014 | 174 | 0.960 |
Why?
| | MicroRNAs | 3 | 2017 | 660 | 0.950 |
Why?
| | Diet | 4 | 2021 | 1178 | 0.940 |
Why?
| | Receptors, Adrenergic, alpha-1 | 7 | 2014 | 41 | 0.920 |
Why?
| | Immunoglobulin M | 10 | 2008 | 253 | 0.910 |
Why?
| | Hippocampus | 18 | 2017 | 756 | 0.910 |
Why?
| | Behavior, Animal | 13 | 2019 | 499 | 0.860 |
Why?
| | Raphe Nuclei | 7 | 2019 | 117 | 0.860 |
Why?
| | Interleukin-1 | 14 | 2008 | 984 | 0.830 |
Why?
| | Antibody Formation | 9 | 2008 | 282 | 0.810 |
Why?
| | Conditioning, Classical | 7 | 2015 | 94 | 0.810 |
Why?
| | Adipose Tissue | 3 | 2016 | 620 | 0.800 |
Why?
| | Glycolipids | 2 | 2019 | 38 | 0.760 |
Why?
| | Feces | 2 | 2020 | 402 | 0.730 |
Why?
| | Neuroendocrine Cells | 1 | 2020 | 30 | 0.730 |
Why?
| | Catecholamines | 7 | 2014 | 106 | 0.720 |
Why?
| | Stress Disorders, Post-Traumatic | 8 | 2021 | 801 | 0.720 |
Why?
| | Microbiota | 2 | 2019 | 683 | 0.700 |
Why?
| | Dopamine | 3 | 2015 | 271 | 0.700 |
Why?
| | Bile Acids and Salts | 1 | 2021 | 180 | 0.700 |
Why?
| | Conditioning, Operant | 5 | 2012 | 105 | 0.700 |
Why?
| | Lipopolysaccharides | 9 | 2014 | 870 | 0.680 |
Why?
| | Receptor, Serotonin, 5-HT2C | 4 | 2012 | 14 | 0.680 |
Why?
| | Glycoproteins | 2 | 2019 | 330 | 0.670 |
Why?
| | Gene Expression Regulation | 8 | 2014 | 2492 | 0.670 |
Why?
| | Tumor Necrosis Factor-alpha | 7 | 2016 | 1198 | 0.650 |
Why?
| | Immunoglobulin G | 11 | 2008 | 808 | 0.650 |
Why?
| | Mentors | 1 | 2021 | 177 | 0.640 |
Why?
| | Microglia | 2 | 2021 | 218 | 0.640 |
Why?
| | Brain-Derived Neurotrophic Factor | 5 | 2018 | 116 | 0.630 |
Why?
| | Sleep | 4 | 2021 | 763 | 0.630 |
Why?
| | Prefrontal Cortex | 5 | 2017 | 281 | 0.630 |
Why?
| | Gastrointestinal Microbiome | 3 | 2020 | 557 | 0.620 |
Why?
| | Interleukin-10 | 7 | 2016 | 311 | 0.620 |
Why?
| | Fatigue | 3 | 2012 | 324 | 0.590 |
Why?
| | Signal Transduction | 10 | 2023 | 4809 | 0.590 |
Why?
| | Alarmins | 1 | 2017 | 25 | 0.590 |
Why?
| | Food Deprivation | 1 | 2016 | 24 | 0.560 |
Why?
| | Vagus Nerve | 7 | 2000 | 82 | 0.550 |
Why?
| | Escape Reaction | 6 | 2012 | 68 | 0.550 |
Why?
| | Inflammation Mediators | 4 | 2013 | 515 | 0.550 |
Why?
| | Receptors, Glucocorticoid | 4 | 2013 | 136 | 0.530 |
Why?
| | Emotions | 3 | 2018 | 525 | 0.530 |
Why?
| | Central Nervous System | 2 | 2016 | 248 | 0.530 |
Why?
| | Butyrates | 1 | 2016 | 55 | 0.530 |
Why?
| | Sleep, REM | 1 | 2016 | 53 | 0.530 |
Why?
| | Analysis of Variance | 15 | 2015 | 1366 | 0.520 |
Why?
| | RNA, Messenger | 12 | 2018 | 2753 | 0.520 |
Why?
| | Body Weight | 12 | 2016 | 959 | 0.520 |
Why?
| | Association Learning | 3 | 2010 | 63 | 0.510 |
Why?
| | Neuroimmunomodulation | 8 | 2003 | 74 | 0.510 |
Why?
| | Mood Disorders | 1 | 2016 | 120 | 0.500 |
Why?
| | T-Lymphocytes | 3 | 2012 | 1793 | 0.500 |
Why?
| | Macrophages, Peritoneal | 2 | 2014 | 97 | 0.490 |
Why?
| | Interleukin-6 | 7 | 2016 | 710 | 0.490 |
Why?
| | Norepinephrine | 6 | 2006 | 227 | 0.490 |
Why?
| | Interleukin-18 | 2 | 2012 | 231 | 0.470 |
Why?
| | Chemokines | 2 | 2012 | 232 | 0.470 |
Why?
| | Serum | 1 | 2014 | 66 | 0.470 |
Why?
| | Adaptation, Physiological | 6 | 2007 | 517 | 0.460 |
Why?
| | Nontuberculous Mycobacteria | 1 | 2016 | 210 | 0.450 |
Why?
| | Sleep Deprivation | 4 | 2020 | 180 | 0.450 |
Why?
| | Receptors, Adrenergic | 1 | 2013 | 38 | 0.450 |
Why?
| | Arousal | 9 | 2021 | 164 | 0.450 |
Why?
| | Reward | 3 | 2016 | 217 | 0.450 |
Why?
| | Adipose Tissue, White | 1 | 2013 | 36 | 0.440 |
Why?
| | Receptor, Serotonin, 5-HT1A | 3 | 2016 | 40 | 0.440 |
Why?
| | Chemokine CCL2 | 4 | 2014 | 128 | 0.430 |
Why?
| | Psychoneuroimmunology | 3 | 2005 | 12 | 0.420 |
Why?
| | Glucocorticoids | 5 | 2012 | 554 | 0.420 |
Why?
| | Immune Tolerance | 3 | 2005 | 338 | 0.420 |
Why?
| | Respiratory Tract Infections | 2 | 2016 | 335 | 0.420 |
Why?
| | Transcortin | 6 | 2007 | 20 | 0.420 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2021 | 524 | 0.410 |
Why?
| | Intestines | 1 | 2015 | 337 | 0.410 |
Why?
| | Time Factors | 23 | 2016 | 6780 | 0.410 |
Why?
| | Injections, Intraperitoneal | 11 | 2008 | 107 | 0.410 |
Why?
| | Antigens | 4 | 2003 | 324 | 0.400 |
Why?
| | Obesity, Abdominal | 1 | 2012 | 41 | 0.400 |
Why?
| | Aminopyridines | 3 | 2009 | 86 | 0.400 |
Why?
| | Mental Health | 2 | 2015 | 594 | 0.390 |
Why?
| | Neurons | 8 | 2017 | 1365 | 0.380 |
Why?
| | Myeloid Cells | 1 | 2012 | 128 | 0.380 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2016 | 340 | 0.380 |
Why?
| | Body Temperature | 5 | 2014 | 236 | 0.370 |
Why?
| | Memory | 9 | 2015 | 241 | 0.360 |
Why?
| | Depression | 3 | 2012 | 1236 | 0.360 |
Why?
| | Limbic System | 1 | 2010 | 44 | 0.360 |
Why?
| | Mifepristone | 3 | 2001 | 67 | 0.360 |
Why?
| | Freezing Reaction, Cataleptic | 4 | 2012 | 23 | 0.360 |
Why?
| | Disease Models, Animal | 13 | 2016 | 3823 | 0.360 |
Why?
| | Indoles | 3 | 2009 | 327 | 0.350 |
Why?
| | Metagenome | 1 | 2010 | 127 | 0.340 |
Why?
| | Volition | 1 | 2009 | 33 | 0.340 |
Why?
| | Extracellular Fluid | 3 | 2006 | 33 | 0.340 |
Why?
| | Random Allocation | 3 | 2016 | 377 | 0.340 |
Why?
| | Brain Chemistry | 3 | 2005 | 135 | 0.330 |
Why?
| | Exercise Therapy | 3 | 2008 | 387 | 0.330 |
Why?
| | Locomotion | 2 | 2012 | 83 | 0.330 |
Why?
| | Space Flight | 2 | 2000 | 130 | 0.330 |
Why?
| | Electric Stimulation | 9 | 2013 | 276 | 0.320 |
Why?
| | Serotonin 5-HT2 Receptor Antagonists | 1 | 2008 | 10 | 0.320 |
Why?
| | Lipid Droplets | 2 | 2019 | 21 | 0.320 |
Why?
| | Predatory Behavior | 5 | 2011 | 41 | 0.320 |
Why?
| | Exercise Test | 3 | 2007 | 585 | 0.310 |
Why?
| | Fluvoxamine | 1 | 2008 | 13 | 0.310 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 7 | 2014 | 837 | 0.310 |
Why?
| | B-Lymphocytes | 2 | 2003 | 781 | 0.310 |
Why?
| | Homeostasis | 3 | 2017 | 605 | 0.300 |
Why?
| | Antibodies | 3 | 2005 | 396 | 0.300 |
Why?
| | Humans | 44 | 2023 | 125131 | 0.290 |
Why?
| | Mycobacterium | 2 | 2021 | 105 | 0.290 |
Why?
| | Adrenalectomy | 11 | 2005 | 81 | 0.290 |
Why?
| | Receptors, Adrenergic, beta | 1 | 2008 | 154 | 0.290 |
Why?
| | Extinction, Psychological | 3 | 2015 | 83 | 0.290 |
Why?
| | Pituitary-Adrenal System | 4 | 2012 | 168 | 0.280 |
Why?
| | Receptors, Catecholamine | 1 | 2006 | 4 | 0.280 |
Why?
| | Hypothalamo-Hypophyseal System | 4 | 2012 | 204 | 0.280 |
Why?
| | Physical Fitness | 2 | 2006 | 185 | 0.270 |
Why?
| | Receptors, Dopamine D2 | 3 | 2014 | 90 | 0.270 |
Why?
| | Heart Rate | 6 | 2016 | 758 | 0.270 |
Why?
| | Extracellular Space | 2 | 2005 | 132 | 0.270 |
Why?
| | Receptors, Adrenergic, alpha | 1 | 2005 | 35 | 0.260 |
Why?
| | Membrane Glycoproteins | 2 | 2005 | 454 | 0.260 |
Why?
| | Neural Pathways | 4 | 2015 | 280 | 0.260 |
Why?
| | Vagotomy | 8 | 2000 | 34 | 0.250 |
Why?
| | Receptor, Serotonin, 5-HT1B | 1 | 2005 | 6 | 0.250 |
Why?
| | Physical Endurance | 1 | 2006 | 237 | 0.250 |
Why?
| | Heat-Shock Response | 1 | 2005 | 59 | 0.250 |
Why?
| | Immunomodulation | 2 | 2017 | 89 | 0.250 |
Why?
| | In Situ Hybridization | 4 | 2012 | 318 | 0.240 |
Why?
| | Adrenal Glands | 7 | 2008 | 76 | 0.240 |
Why?
| | Adrenocorticotropic Hormone | 7 | 2013 | 154 | 0.240 |
Why?
| | Psychomotor Performance | 3 | 2019 | 304 | 0.240 |
Why?
| | Long-Term Potentiation | 7 | 1999 | 151 | 0.240 |
Why?
| | Sick Role | 1 | 2004 | 22 | 0.240 |
Why?
| | Memory Disorders | 3 | 2013 | 173 | 0.230 |
Why?
| | Cognition | 5 | 2019 | 1069 | 0.230 |
Why?
| | Membrane Transport Proteins | 1 | 2005 | 143 | 0.230 |
Why?
| | Encephalitis | 1 | 2005 | 129 | 0.220 |
Why?
| | Morphine | 5 | 2011 | 153 | 0.220 |
Why?
| | Adjuvants, Immunologic | 3 | 2003 | 211 | 0.220 |
Why?
| | CD5 Antigens | 1 | 2003 | 8 | 0.220 |
Why?
| | Lung | 1 | 2016 | 3865 | 0.220 |
Why?
| | CD11 Antigens | 1 | 2003 | 32 | 0.220 |
Why?
| | Social Behavior | 4 | 2016 | 301 | 0.220 |
Why?
| | Protein Biosynthesis | 1 | 2005 | 416 | 0.210 |
Why?
| | Hypothalamus | 4 | 2017 | 161 | 0.210 |
Why?
| | Muscle Strength | 1 | 2006 | 294 | 0.210 |
Why?
| | Propranolol | 3 | 2008 | 53 | 0.210 |
Why?
| | Genes, fos | 1 | 2003 | 37 | 0.210 |
Why?
| | Nitric Oxide | 4 | 2014 | 886 | 0.200 |
Why?
| | Microdialysis | 4 | 2015 | 65 | 0.200 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2000 | 997 | 0.200 |
Why?
| | Sex Characteristics | 2 | 2006 | 699 | 0.200 |
Why?
| | Depressive Disorder | 3 | 2012 | 361 | 0.200 |
Why?
| | Dose-Response Relationship, Drug | 9 | 2013 | 2026 | 0.200 |
Why?
| | Maze Learning | 6 | 2015 | 86 | 0.200 |
Why?
| | Dehydroepiandrosterone | 3 | 1997 | 51 | 0.200 |
Why?
| | Bacteroidetes | 1 | 2021 | 22 | 0.190 |
Why?
| | T-Lymphocyte Subsets | 2 | 1995 | 406 | 0.190 |
Why?
| | Dehydroepiandrosterone Sulfate | 3 | 1999 | 45 | 0.190 |
Why?
| | Interferon-gamma | 4 | 2001 | 749 | 0.190 |
Why?
| | Tyrosine 3-Monooxygenase | 3 | 2016 | 74 | 0.190 |
Why?
| | Nerve Tissue Proteins | 1 | 2005 | 563 | 0.190 |
Why?
| | Weightlessness Simulation | 1 | 2000 | 13 | 0.190 |
Why?
| | Gene Expression | 2 | 2018 | 1528 | 0.180 |
Why?
| | Immunization | 5 | 2021 | 420 | 0.180 |
Why?
| | Pituitary Gland | 5 | 2006 | 165 | 0.180 |
Why?
| | Adrenergic beta-Antagonists | 3 | 2008 | 339 | 0.180 |
Why?
| | Acoustic Stimulation | 7 | 2015 | 328 | 0.180 |
Why?
| | Antidepressive Agents, Tricyclic | 2 | 2013 | 32 | 0.180 |
Why?
| | Neurosecretory Systems | 1 | 2000 | 33 | 0.180 |
Why?
| | Weightlessness | 1 | 2000 | 80 | 0.180 |
Why?
| | Mental Recall | 4 | 1997 | 187 | 0.180 |
Why?
| | Radiation Effects | 1 | 1999 | 4 | 0.170 |
Why?
| | Astronauts | 1 | 1999 | 19 | 0.170 |
Why?
| | Dentate Gyrus | 2 | 2010 | 32 | 0.170 |
Why?
| | Myocardium | 3 | 2007 | 992 | 0.170 |
Why?
| | Avoidance Learning | 2 | 2013 | 69 | 0.170 |
Why?
| | Exploratory Behavior | 3 | 2015 | 91 | 0.170 |
Why?
| | Chromatography, Liquid | 1 | 2021 | 363 | 0.170 |
Why?
| | Fever | 3 | 2011 | 294 | 0.170 |
Why?
| | Serotonergic Neurons | 1 | 2019 | 24 | 0.170 |
Why?
| | Citrate (si)-Synthase | 4 | 2007 | 48 | 0.170 |
Why?
| | Tryptophan Hydroxylase | 1 | 2019 | 51 | 0.170 |
Why?
| | Prazosin | 2 | 2011 | 26 | 0.160 |
Why?
| | Sleep Disorders, Circadian Rhythm | 1 | 2019 | 48 | 0.160 |
Why?
| | Tandem Mass Spectrometry | 1 | 2021 | 431 | 0.160 |
Why?
| | RNA, Bacterial | 1 | 2020 | 176 | 0.160 |
Why?
| | Serotonin 5-HT2 Receptor Agonists | 2 | 2008 | 5 | 0.160 |
Why?
| | Lymph Nodes | 4 | 2006 | 467 | 0.160 |
Why?
| | Analgesics, Opioid | 3 | 2012 | 820 | 0.150 |
Why?
| | Dexamethasone | 3 | 2001 | 329 | 0.150 |
Why?
| | Toll-Like Receptors | 2 | 2011 | 170 | 0.150 |
Why?
| | Cats | 5 | 2015 | 208 | 0.150 |
Why?
| | Up-Regulation | 3 | 2012 | 895 | 0.150 |
Why?
| | Peptides | 2 | 2013 | 884 | 0.150 |
Why?
| | Immunosuppressive Agents | 1 | 2001 | 693 | 0.140 |
Why?
| | Exercise Movement Techniques | 1 | 2016 | 4 | 0.140 |
Why?
| | Aging | 3 | 2004 | 1706 | 0.140 |
Why?
| | Immunoglobulins | 1 | 1996 | 155 | 0.130 |
Why?
| | Leukocyte Count | 3 | 2002 | 315 | 0.130 |
Why?
| | Vaccines, Inactivated | 1 | 2016 | 69 | 0.130 |
Why?
| | Behavior | 2 | 2006 | 100 | 0.130 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2016 | 174 | 0.130 |
Why?
| | Bacterial Vaccines | 1 | 2016 | 62 | 0.130 |
Why?
| | Muscle, Skeletal | 5 | 2007 | 1568 | 0.130 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2016 | 123 | 0.130 |
Why?
| | Dysgammaglobulinemia | 1 | 1995 | 2 | 0.130 |
Why?
| | IgG Deficiency | 1 | 1995 | 10 | 0.130 |
Why?
| | Tertiary Care Centers | 1 | 2016 | 137 | 0.130 |
Why?
| | Leptin | 1 | 2016 | 233 | 0.120 |
Why?
| | Host-Pathogen Interactions | 2 | 2015 | 312 | 0.120 |
Why?
| | Leukocyte Common Antigens | 1 | 1995 | 79 | 0.120 |
Why?
| | Symbiosis | 1 | 2015 | 65 | 0.120 |
Why?
| | Lymphocyte Culture Test, Mixed | 1 | 1995 | 46 | 0.120 |
Why?
| | Metabolomics | 1 | 2020 | 551 | 0.120 |
Why?
| | CD4 Antigens | 1 | 1995 | 127 | 0.120 |
Why?
| | Hydrocortisone | 3 | 2015 | 289 | 0.120 |
Why?
| | Neuralgia | 1 | 2016 | 122 | 0.120 |
Why?
| | Blood Proteins | 1 | 1997 | 253 | 0.120 |
Why?
| | Enkephalins | 1 | 2014 | 15 | 0.120 |
Why?
| | Dynorphins | 1 | 2014 | 9 | 0.120 |
Why?
| | Receptor, Adenosine A1 | 1 | 2014 | 11 | 0.120 |
Why?
| | Tyrosine | 2 | 2005 | 243 | 0.120 |
Why?
| | Culture Media | 1 | 2014 | 164 | 0.120 |
Why?
| | Receptors, Dopamine D1 | 1 | 2014 | 28 | 0.120 |
Why?
| | Receptor, Adenosine A2A | 1 | 2014 | 21 | 0.120 |
Why?
| | Nitrites | 3 | 2016 | 80 | 0.120 |
Why?
| | Anxiety Disorders | 2 | 2008 | 333 | 0.120 |
Why?
| | Convulsants | 1 | 1993 | 7 | 0.120 |
Why?
| | Tail | 4 | 1998 | 35 | 0.120 |
Why?
| | Primary Cell Culture | 1 | 2014 | 155 | 0.110 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2017 | 379 | 0.110 |
Why?
| | Adrenal Cortex Hormones | 3 | 2006 | 524 | 0.110 |
Why?
| | Adrenergic alpha-Antagonists | 2 | 2005 | 31 | 0.110 |
Why?
| | Carbolines | 1 | 1993 | 29 | 0.110 |
Why?
| | Acute-Phase Reaction | 2 | 2007 | 39 | 0.110 |
Why?
| | Hyperalgesia | 3 | 2016 | 107 | 0.110 |
Why?
| | Colitis | 1 | 2016 | 226 | 0.110 |
Why?
| | Kaplan-Meier Estimate | 1 | 2016 | 879 | 0.110 |
Why?
| | HSP90 Heat-Shock Proteins | 1 | 2013 | 46 | 0.110 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2013 | 74 | 0.110 |
Why?
| | Molecular Probes | 1 | 2013 | 31 | 0.110 |
Why?
| | Pulmonary Fibrosis | 1 | 2016 | 310 | 0.110 |
Why?
| | Bradykinin | 1 | 2013 | 48 | 0.110 |
Why?
| | Amnesia | 2 | 2011 | 46 | 0.110 |
Why?
| | Telemetry | 1 | 2013 | 36 | 0.110 |
Why?
| | Reaction Time | 3 | 2012 | 411 | 0.110 |
Why?
| | Cues | 3 | 2015 | 315 | 0.110 |
Why?
| | Diaphragm | 3 | 1998 | 45 | 0.110 |
Why?
| | Membrane Proteins | 2 | 2012 | 1089 | 0.110 |
Why?
| | Fetal Blood | 1 | 2014 | 278 | 0.110 |
Why?
| | Macrophage Inflammatory Proteins | 1 | 2012 | 12 | 0.110 |
Why?
| | Proportional Hazards Models | 1 | 2016 | 1191 | 0.110 |
Why?
| | Synaptotagmin I | 1 | 2012 | 13 | 0.100 |
Why?
| | Life Style | 2 | 2005 | 442 | 0.100 |
Why?
| | Thymus Gland | 3 | 2008 | 301 | 0.100 |
Why?
| | Mental Disorders | 1 | 2020 | 976 | 0.100 |
Why?
| | Phenylephrine | 2 | 2001 | 85 | 0.100 |
Why?
| | Macrophages | 2 | 2000 | 1333 | 0.100 |
Why?
| | Caspase Inhibitors | 1 | 2012 | 82 | 0.100 |
Why?
| | Injections, Subcutaneous | 2 | 2003 | 139 | 0.100 |
Why?
| | Body Fat Distribution | 1 | 2012 | 48 | 0.100 |
Why?
| | Lipid Bilayers | 1 | 2013 | 102 | 0.100 |
Why?
| | Aged | 5 | 2008 | 20859 | 0.100 |
Why?
| | Female | 20 | 2019 | 64889 | 0.100 |
Why?
| | Rats, Nude | 1 | 2012 | 26 | 0.100 |
Why?
| | Area Under Curve | 1 | 2013 | 305 | 0.100 |
Why?
| | Gliosarcoma | 1 | 1992 | 8 | 0.100 |
Why?
| | Cell Communication | 1 | 2014 | 282 | 0.100 |
Why?
| | Thiazepines | 2 | 2013 | 5 | 0.100 |
Why?
| | Caspase 1 | 1 | 2012 | 143 | 0.100 |
Why?
| | Lymphocyte Transfusion | 1 | 1992 | 19 | 0.100 |
Why?
| | Lymphocyte Count | 2 | 2003 | 140 | 0.100 |
Why?
| | Saimiri | 1 | 2011 | 6 | 0.100 |
Why?
| | Cattle | 1 | 2014 | 1010 | 0.100 |
Why?
| | Lymphocytes | 3 | 2011 | 356 | 0.100 |
Why?
| | Locus Coeruleus | 1 | 2011 | 22 | 0.100 |
Why?
| | Neurobiology | 1 | 2011 | 18 | 0.100 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2011 | 38 | 0.100 |
Why?
| | Biosensing Techniques | 1 | 2012 | 113 | 0.090 |
Why?
| | Cell Survival | 1 | 2014 | 1081 | 0.090 |
Why?
| | Body Composition | 1 | 2015 | 679 | 0.090 |
Why?
| | Laparotomy | 1 | 2011 | 109 | 0.090 |
Why?
| | Receptors, Opioid, delta | 1 | 2010 | 8 | 0.090 |
Why?
| | Cells, Cultured | 3 | 2014 | 4159 | 0.090 |
Why?
| | Endocrine Glands | 1 | 1990 | 16 | 0.090 |
Why?
| | Peptides, Cyclic | 1 | 2012 | 265 | 0.090 |
Why?
| | Interleukin-2 | 1 | 1992 | 424 | 0.090 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2011 | 334 | 0.090 |
Why?
| | DNA Primers | 1 | 2011 | 545 | 0.090 |
Why?
| | Microinjections | 2 | 2008 | 84 | 0.090 |
Why?
| | Rats, Inbred Strains | 6 | 1995 | 414 | 0.090 |
Why?
| | Mice | 7 | 2021 | 15984 | 0.090 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2012 | 410 | 0.090 |
Why?
| | Epinephrine | 3 | 2004 | 170 | 0.090 |
Why?
| | Immunotherapy, Adoptive | 1 | 1992 | 194 | 0.090 |
Why?
| | Cell Count | 2 | 2002 | 321 | 0.090 |
Why?
| | Stress Disorders, Traumatic | 1 | 2009 | 25 | 0.080 |
Why?
| | Pain | 4 | 2011 | 767 | 0.080 |
Why?
| | Toll-Like Receptor 4 | 1 | 2012 | 333 | 0.080 |
Why?
| | Immunohistochemistry | 3 | 2019 | 1743 | 0.080 |
Why?
| | CA1 Region, Hippocampal | 1 | 2009 | 30 | 0.080 |
Why?
| | Insulin | 2 | 2016 | 2219 | 0.080 |
Why?
| | Uric Acid | 1 | 2012 | 353 | 0.080 |
Why?
| | Glucose | 1 | 2014 | 995 | 0.080 |
Why?
| | Naltrexone | 4 | 1994 | 80 | 0.080 |
Why?
| | Antihypertensive Agents | 1 | 2013 | 471 | 0.080 |
Why?
| | Analgesics | 1 | 1990 | 172 | 0.080 |
Why?
| | Immunologic Deficiency Syndromes | 3 | 2001 | 72 | 0.080 |
Why?
| | Neutrophils | 3 | 2011 | 1250 | 0.080 |
Why?
| | Lipids | 1 | 2012 | 629 | 0.080 |
Why?
| | Reference Values | 5 | 2007 | 818 | 0.080 |
Why?
| | Nadolol | 1 | 2008 | 5 | 0.080 |
Why?
| | Weight Loss | 1 | 1993 | 677 | 0.080 |
Why?
| | Flow Cytometry | 2 | 2003 | 1108 | 0.080 |
Why?
| | Habituation, Psychophysiologic | 1 | 2008 | 56 | 0.080 |
Why?
| | Pyrazines | 1 | 2008 | 80 | 0.080 |
Why?
| | Immunity | 2 | 2000 | 130 | 0.080 |
Why?
| | Isoproterenol | 1 | 2008 | 137 | 0.070 |
Why?
| | Substantia Nigra | 1 | 2008 | 38 | 0.070 |
Why?
| | Nerve Net | 1 | 2010 | 236 | 0.070 |
Why?
| | Injections, Intraventricular | 4 | 1998 | 82 | 0.070 |
Why?
| | Reinforcement Schedule | 1 | 2007 | 30 | 0.070 |
Why?
| | Adrenergic beta-Agonists | 1 | 2008 | 137 | 0.070 |
Why?
| | Blood Glucose | 1 | 2016 | 2008 | 0.070 |
Why?
| | Computational Biology | 1 | 2011 | 616 | 0.070 |
Why?
| | Aggression | 1 | 1989 | 218 | 0.070 |
Why?
| | Mesentery | 2 | 1998 | 59 | 0.070 |
Why?
| | Biogenic Monoamines | 1 | 2006 | 14 | 0.070 |
Why?
| | Antidepressive Agents, Second-Generation | 1 | 2006 | 38 | 0.070 |
Why?
| | Adaptation, Psychological | 1 | 2011 | 614 | 0.070 |
Why?
| | Fluoxetine | 1 | 2006 | 47 | 0.070 |
Why?
| | Recombinant Proteins | 5 | 2000 | 1327 | 0.070 |
Why?
| | Estrous Cycle | 1 | 2006 | 17 | 0.070 |
Why?
| | Piperazines | 1 | 2008 | 331 | 0.070 |
Why?
| | Tomography, X-Ray Computed | 1 | 2016 | 2539 | 0.070 |
Why?
| | Immunity, Cellular | 2 | 2005 | 277 | 0.070 |
Why?
| | Cell Adhesion Molecules | 1 | 2007 | 182 | 0.070 |
Why?
| | Labetalol | 1 | 2005 | 6 | 0.060 |
Why?
| | Peritoneum | 2 | 2003 | 36 | 0.060 |
Why?
| | Mianserin | 1 | 2005 | 3 | 0.060 |
Why?
| | Methyltyrosines | 1 | 2005 | 4 | 0.060 |
Why?
| | Hypophysectomy | 1 | 2005 | 15 | 0.060 |
Why?
| | Immunoglobulin alpha-Chains | 1 | 2005 | 2 | 0.060 |
Why?
| | Hypertrophy | 2 | 2007 | 125 | 0.060 |
Why?
| | Pulmonary Edema | 1 | 2006 | 144 | 0.060 |
Why?
| | Postural Balance | 1 | 2008 | 198 | 0.060 |
Why?
| | Evoked Potentials | 3 | 1996 | 122 | 0.060 |
Why?
| | RNA | 1 | 2011 | 875 | 0.060 |
Why?
| | Phosphorylation | 3 | 2017 | 1694 | 0.060 |
Why?
| | Exocytosis | 1 | 2005 | 91 | 0.060 |
Why?
| | Spectrophotometry | 1 | 2005 | 55 | 0.060 |
Why?
| | Specific Pathogen-Free Organisms | 2 | 2002 | 65 | 0.060 |
Why?
| | Liver | 3 | 2006 | 1872 | 0.060 |
Why?
| | Chemokines, CX3C | 1 | 2004 | 10 | 0.060 |
Why?
| | Hypertension, Pulmonary | 1 | 2016 | 1880 | 0.060 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 1 | 2005 | 74 | 0.060 |
Why?
| | Progesterone | 1 | 2006 | 243 | 0.060 |
Why?
| | Receptors, Corticotropin-Releasing Hormone | 1 | 2004 | 33 | 0.060 |
Why?
| | HIV Envelope Protein gp120 | 1 | 2004 | 65 | 0.060 |
Why?
| | Lymphocyte Activation | 2 | 2000 | 1077 | 0.060 |
Why?
| | Antibody Specificity | 1 | 2004 | 191 | 0.060 |
Why?
| | Down-Regulation | 1 | 2006 | 652 | 0.060 |
Why?
| | Concanavalin A | 1 | 2003 | 76 | 0.060 |
Why?
| | Cholesterol, HDL | 1 | 2005 | 217 | 0.060 |
Why?
| | Blood Pressure | 4 | 2015 | 1735 | 0.060 |
Why?
| | Hypertension | 1 | 2013 | 1257 | 0.060 |
Why?
| | Brain Neoplasms | 1 | 1992 | 1040 | 0.060 |
Why?
| | Fatigue Syndrome, Chronic | 1 | 2003 | 16 | 0.060 |
Why?
| | Nitric Oxide Synthase | 1 | 2004 | 226 | 0.060 |
Why?
| | Immunologic Factors | 1 | 2005 | 228 | 0.060 |
Why?
| | Biomarkers | 3 | 2015 | 3736 | 0.060 |
Why?
| | Mice, Inbred C57BL | 4 | 2021 | 5102 | 0.060 |
Why?
| | History, 21st Century | 1 | 2004 | 181 | 0.060 |
Why?
| | Receptors, Serotonin, 5-HT1 | 1 | 2003 | 6 | 0.060 |
Why?
| | Frontal Lobe | 1 | 2004 | 152 | 0.050 |
Why?
| | Leukocytes | 1 | 2005 | 292 | 0.050 |
Why?
| | Estrogens | 1 | 2006 | 337 | 0.050 |
Why?
| | Receptors, Cell Surface | 1 | 2005 | 368 | 0.050 |
Why?
| | Pulmonary Alveoli | 1 | 2006 | 399 | 0.050 |
Why?
| | Receptors, Serotonin | 1 | 2003 | 38 | 0.050 |
Why?
| | History, 20th Century | 1 | 2004 | 290 | 0.050 |
Why?
| | Hot Temperature | 2 | 2021 | 345 | 0.050 |
Why?
| | Hemoglobins | 1 | 2005 | 299 | 0.050 |
Why?
| | Analgesia | 2 | 1994 | 86 | 0.050 |
Why?
| | Cholesterol, LDL | 1 | 2005 | 341 | 0.050 |
Why?
| | Naloxone | 3 | 2012 | 93 | 0.050 |
Why?
| | Nucleus Accumbens | 2 | 2016 | 134 | 0.050 |
Why?
| | Risk Factors | 1 | 2016 | 9549 | 0.050 |
Why?
| | Triglycerides | 1 | 2005 | 551 | 0.050 |
Why?
| | Immunologic Memory | 1 | 2004 | 322 | 0.050 |
Why?
| | Forecasting | 1 | 2004 | 379 | 0.050 |
Why?
| | Pathogen-Associated Molecular Pattern Molecules | 1 | 2021 | 6 | 0.050 |
Why?
| | Tissue Distribution | 1 | 2003 | 342 | 0.050 |
Why?
| | Cell Membrane | 1 | 2005 | 732 | 0.050 |
Why?
| | Reflex, Startle | 2 | 2015 | 65 | 0.050 |
Why?
| | Cell Division | 1 | 2003 | 796 | 0.050 |
Why?
| | Epitopes | 1 | 2003 | 450 | 0.050 |
Why?
| | Adult | 9 | 2019 | 33167 | 0.050 |
Why?
| | Immunoglobulin Isotypes | 1 | 2001 | 31 | 0.050 |
Why?
| | Injections, Intravenous | 2 | 1998 | 219 | 0.050 |
Why?
| | Mycobacteriaceae | 1 | 2021 | 21 | 0.050 |
Why?
| | Learning | 3 | 2008 | 401 | 0.050 |
Why?
| | Neurons, Afferent | 2 | 1998 | 90 | 0.050 |
Why?
| | Hormone Antagonists | 1 | 2001 | 42 | 0.050 |
Why?
| | Macrophage-1 Antigen | 1 | 2000 | 36 | 0.050 |
Why?
| | Spironolactone | 1 | 2001 | 38 | 0.050 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 99 | 0.050 |
Why?
| | Skin | 2 | 2002 | 698 | 0.050 |
Why?
| | Complement Activation | 1 | 2003 | 350 | 0.050 |
Why?
| | Health Status | 1 | 2006 | 794 | 0.040 |
Why?
| | Hypogravity | 1 | 1999 | 5 | 0.040 |
Why?
| | Drug Combinations | 1 | 2001 | 298 | 0.040 |
Why?
| | Obesity | 1 | 1993 | 2805 | 0.040 |
Why?
| | Phenotype | 2 | 2021 | 3153 | 0.040 |
Why?
| | Receptors, Mineralocorticoid | 1 | 1999 | 12 | 0.040 |
Why?
| | Radiation Injuries, Experimental | 1 | 1999 | 25 | 0.040 |
Why?
| | Cells | 1 | 1999 | 24 | 0.040 |
Why?
| | Radiometry | 1 | 1999 | 45 | 0.040 |
Why?
| | Chronic Disease | 1 | 2006 | 1684 | 0.040 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 1999 | 131 | 0.040 |
Why?
| | Erythrocytes | 1 | 2005 | 642 | 0.040 |
Why?
| | Electrophysiology | 2 | 1999 | 205 | 0.040 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 1999 | 74 | 0.040 |
Why?
| | United States | 1 | 2016 | 13613 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2021 | 654 | 0.040 |
Why?
| | Social Isolation | 1 | 1999 | 68 | 0.040 |
Why?
| | C-Reactive Protein | 2 | 2015 | 381 | 0.040 |
Why?
| | Electroencephalography | 1 | 2021 | 400 | 0.040 |
Why?
| | Restraint, Physical | 3 | 2010 | 96 | 0.040 |
Why?
| | Retrospective Studies | 1 | 2016 | 13708 | 0.040 |
Why?
| | Mitochondria, Heart | 1 | 1999 | 85 | 0.040 |
Why?
| | Endotoxins | 1 | 2000 | 237 | 0.040 |
Why?
| | Staphylococcal Infections | 2 | 2000 | 347 | 0.040 |
Why?
| | Peritoneal Cavity | 1 | 1998 | 24 | 0.040 |
Why?
| | Eating | 3 | 2000 | 388 | 0.040 |
Why?
| | Middle Aged | 3 | 2016 | 29112 | 0.040 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1999 | 340 | 0.040 |
Why?
| | Administration, Oral | 1 | 2001 | 785 | 0.040 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 3 | 2007 | 256 | 0.040 |
Why?
| | Bacteriophages | 1 | 1999 | 75 | 0.040 |
Why?
| | Polysomnography | 1 | 2019 | 179 | 0.040 |
Why?
| | Wakefulness | 1 | 2019 | 141 | 0.040 |
Why?
| | Amino Acid Sequence | 2 | 2012 | 2098 | 0.040 |
Why?
| | Task Performance and Analysis | 1 | 2019 | 169 | 0.040 |
Why?
| | Individuality | 1 | 2019 | 151 | 0.040 |
Why?
| | Antigens, CD | 1 | 2000 | 466 | 0.040 |
Why?
| | Escherichia coli | 1 | 2002 | 766 | 0.040 |
Why?
| | Anesthesia | 2 | 1990 | 122 | 0.040 |
Why?
| | CD4 Lymphocyte Count | 1 | 1998 | 273 | 0.040 |
Why?
| | Models, Biological | 1 | 2005 | 1753 | 0.040 |
Why?
| | Models, Molecular | 2 | 2013 | 1450 | 0.040 |
Why?
| | alpha-MSH | 1 | 1998 | 58 | 0.040 |
Why?
| | Molecular Sequence Data | 2 | 2012 | 2926 | 0.040 |
Why?
| | Oxytocics | 1 | 1997 | 18 | 0.040 |
Why?
| | Altitude | 1 | 2001 | 461 | 0.040 |
Why?
| | Cell Transformation, Neoplastic | 1 | 1999 | 332 | 0.040 |
Why?
| | Weight Gain | 1 | 2000 | 517 | 0.040 |
Why?
| | Monitoring, Physiologic | 2 | 2008 | 290 | 0.040 |
Why?
| | Receptors, Purinergic P2X5 | 1 | 2016 | 4 | 0.030 |
Why?
| | Activating Transcription Factor 3 | 1 | 2016 | 6 | 0.030 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 1993 | 3471 | 0.030 |
Why?
| | Excitatory Amino Acid Transporter 2 | 1 | 2016 | 13 | 0.030 |
Why?
| | Dinoprostone | 1 | 1997 | 195 | 0.030 |
Why?
| | p21-Activated Kinases | 1 | 2016 | 14 | 0.030 |
Why?
| | Ganglia, Spinal | 1 | 2016 | 45 | 0.030 |
Why?
| | Sciatic Neuropathy | 1 | 2016 | 24 | 0.030 |
Why?
| | Occupational Exposure | 1 | 1999 | 314 | 0.030 |
Why?
| | Orientation | 1 | 1996 | 46 | 0.030 |
Why?
| | Blotting, Western | 1 | 1999 | 1233 | 0.030 |
Why?
| | Synaptic Transmission | 1 | 1998 | 247 | 0.030 |
Why?
| | Attention | 1 | 2019 | 442 | 0.030 |
Why?
| | Electron Transport Complex IV | 1 | 1996 | 54 | 0.030 |
Why?
| | Neuroglia | 1 | 2017 | 157 | 0.030 |
Why?
| | Receptors, Interleukin-1 | 1 | 1997 | 230 | 0.030 |
Why?
| | Azides | 1 | 1996 | 49 | 0.030 |
Why?
| | Constriction, Pathologic | 1 | 2016 | 216 | 0.030 |
Why?
| | Functional Laterality | 1 | 2016 | 212 | 0.030 |
Why?
| | Microfilament Proteins | 1 | 2016 | 135 | 0.030 |
Why?
| | Dopaminergic Neurons | 1 | 2016 | 44 | 0.030 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 292 | 0.030 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2016 | 150 | 0.030 |
Why?
| | Spinal Cord | 2 | 2004 | 365 | 0.030 |
Why?
| | Stem Cells | 1 | 1999 | 570 | 0.030 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2016 | 145 | 0.030 |
Why?
| | Immobilization | 1 | 2015 | 48 | 0.030 |
Why?
| | Calcium-Binding Proteins | 1 | 2016 | 221 | 0.030 |
Why?
| | Nylons | 1 | 1995 | 19 | 0.030 |
Why?
| | Cytological Techniques | 1 | 1995 | 24 | 0.030 |
Why?
| | Drug Synergism | 2 | 2011 | 344 | 0.030 |
Why?
| | Executive Function | 1 | 2019 | 408 | 0.030 |
Why?
| | Neck | 1 | 1995 | 92 | 0.030 |
Why?
| | Macrophage Activation | 1 | 1996 | 163 | 0.030 |
Why?
| | Mice, Inbred BALB C | 2 | 2012 | 1233 | 0.030 |
Why?
| | Cholesterol | 1 | 1996 | 390 | 0.030 |
Why?
| | Melatonin | 1 | 2015 | 117 | 0.030 |
Why?
| | Surveys and Questionnaires | 1 | 2006 | 5061 | 0.030 |
Why?
| | Leukocytes, Mononuclear | 1 | 2016 | 517 | 0.030 |
Why?
| | Neurogenesis | 1 | 2014 | 105 | 0.030 |
Why?
| | Memory, Short-Term | 2 | 2008 | 239 | 0.030 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2016 | 364 | 0.030 |
Why?
| | Fasting | 1 | 2014 | 269 | 0.030 |
Why?
| | Clonidine | 1 | 2013 | 28 | 0.030 |
Why?
| | CD4-CD8 Ratio | 1 | 1992 | 20 | 0.030 |
Why?
| | Neural Inhibition | 1 | 1994 | 163 | 0.030 |
Why?
| | Static Electricity | 1 | 2013 | 122 | 0.030 |
Why?
| | Myristoylated Alanine-Rich C Kinase Substrate | 1 | 2012 | 5 | 0.030 |
Why?
| | Amitriptyline | 1 | 2013 | 24 | 0.030 |
Why?
| | Phosphatidylserines | 1 | 2013 | 91 | 0.030 |
Why?
| | Unilamellar Liposomes | 1 | 2012 | 11 | 0.030 |
Why?
| | Drug Administration Routes | 1 | 2012 | 45 | 0.030 |
Why?
| | Spectrometry, Fluorescence | 1 | 2013 | 172 | 0.030 |
Why?
| | Adolescent Health Services | 1 | 1993 | 69 | 0.030 |
Why?
| | Anthropometry | 1 | 1993 | 205 | 0.030 |
Why?
| | Circular Dichroism | 1 | 2012 | 138 | 0.030 |
Why?
| | Pituitary-Adrenal Function Tests | 1 | 2012 | 2 | 0.030 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 1 | 2012 | 88 | 0.030 |
Why?
| | Pain Threshold | 1 | 2012 | 76 | 0.030 |
Why?
| | Hand Strength | 2 | 2004 | 107 | 0.030 |
Why?
| | Protein Multimerization | 1 | 2013 | 163 | 0.030 |
Why?
| | Sex Factors | 2 | 2008 | 1901 | 0.030 |
Why?
| | Self Administration | 1 | 2012 | 126 | 0.020 |
Why?
| | Membranes, Artificial | 1 | 2012 | 79 | 0.020 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2012 | 97 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2006 | 9790 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2012 | 178 | 0.020 |
Why?
| | Sialoglycoproteins | 2 | 2004 | 162 | 0.020 |
Why?
| | Neoplasm Transplantation | 1 | 1992 | 250 | 0.020 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 1992 | 160 | 0.020 |
Why?
| | Linear Models | 2 | 2004 | 870 | 0.020 |
Why?
| | Liposomes | 1 | 2012 | 160 | 0.020 |
Why?
| | Adolescent | 3 | 2004 | 19411 | 0.020 |
Why?
| | Narcotic Antagonists | 1 | 2012 | 133 | 0.020 |
Why?
| | Fluorescent Dyes | 1 | 2012 | 319 | 0.020 |
Why?
| | Arginine Vasopressin | 1 | 1990 | 60 | 0.020 |
Why?
| | Behavior Therapy | 1 | 1993 | 254 | 0.020 |
Why?
| | Aged, 80 and over | 3 | 2008 | 6936 | 0.020 |
Why?
| | Pentobarbital | 1 | 1990 | 29 | 0.020 |
Why?
| | Urethane | 1 | 1990 | 40 | 0.020 |
Why?
| | Risk Assessment | 1 | 1999 | 3274 | 0.020 |
Why?
| | Vasopressins | 1 | 1990 | 68 | 0.020 |
Why?
| | 8-Hydroxy-2-(di-n-propylamino)tetralin | 1 | 2009 | 11 | 0.020 |
Why?
| | Immunity, Mucosal | 1 | 2011 | 86 | 0.020 |
Why?
| | Radioimmunoassay | 1 | 2010 | 170 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 1992 | 902 | 0.020 |
Why?
| | Serotonin Receptor Agonists | 1 | 2009 | 28 | 0.020 |
Why?
| | Serotonin Antagonists | 1 | 2009 | 32 | 0.020 |
Why?
| | Noise | 1 | 2010 | 66 | 0.020 |
Why?
| | Drinking | 2 | 1999 | 37 | 0.020 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2011 | 159 | 0.020 |
Why?
| | Bites and Stings | 1 | 1989 | 31 | 0.020 |
Why?
| | Program Evaluation | 1 | 1993 | 896 | 0.020 |
Why?
| | Nanoparticles | 1 | 2012 | 328 | 0.020 |
Why?
| | Posture | 1 | 1989 | 172 | 0.020 |
Why?
| | Organ Size | 1 | 2008 | 479 | 0.020 |
Why?
| | Injections, Intramuscular | 1 | 2008 | 133 | 0.020 |
Why?
| | Amine Oxidase (Copper-Containing) | 1 | 2007 | 5 | 0.020 |
Why?
| | E-Selectin | 1 | 2007 | 54 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2009 | 830 | 0.020 |
Why?
| | Atrophy | 1 | 2007 | 166 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2012 | 2061 | 0.020 |
Why?
| | Protein Binding | 1 | 2012 | 2014 | 0.020 |
Why?
| | Action Potentials | 3 | 1999 | 434 | 0.020 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2007 | 178 | 0.020 |
Why?
| | Epithelial Sodium Channels | 1 | 2006 | 12 | 0.020 |
Why?
| | Biological Transport, Active | 1 | 2006 | 74 | 0.020 |
Why?
| | Sodium Channels | 1 | 2006 | 65 | 0.020 |
Why?
| | Cell Line | 1 | 1992 | 2806 | 0.020 |
Why?
| | Models, Animal | 1 | 2007 | 373 | 0.020 |
Why?
| | Epithelium | 1 | 2006 | 318 | 0.020 |
Why?
| | Autoimmunity | 1 | 1991 | 835 | 0.020 |
Why?
| | Receptors, HIV | 1 | 2004 | 23 | 0.020 |
Why?
| | CX3C Chemokine Receptor 1 | 1 | 2004 | 19 | 0.020 |
Why?
| | Chemokine CX3CL1 | 1 | 2004 | 22 | 0.010 |
Why?
| | Receptors, Cytokine | 1 | 2004 | 34 | 0.010 |
Why?
| | Bronchi | 1 | 2006 | 259 | 0.010 |
Why?
| | Nitric Oxide Synthase Type I | 1 | 2004 | 26 | 0.010 |
Why?
| | Injections, Spinal | 1 | 2004 | 102 | 0.010 |
Why?
| | Drug Implants | 2 | 1996 | 73 | 0.010 |
Why?
| | Drug Tolerance | 1 | 2004 | 135 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2006 | 1144 | 0.010 |
Why?
| | Complement C4a | 1 | 2003 | 7 | 0.010 |
Why?
| | Hormones | 1 | 2004 | 136 | 0.010 |
Why?
| | Histamine | 1 | 2003 | 63 | 0.010 |
Why?
| | Catheterization | 1 | 2004 | 161 | 0.010 |
Why?
| | Social Environment | 2 | 1996 | 309 | 0.010 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2004 | 163 | 0.010 |
Why?
| | Osmolar Concentration | 1 | 2003 | 196 | 0.010 |
Why?
| | Isometric Contraction | 1 | 2004 | 158 | 0.010 |
Why?
| | Genetic Therapy | 1 | 2004 | 267 | 0.010 |
Why?
| | Electromyography | 1 | 2004 | 339 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2004 | 863 | 0.010 |
Why?
| | Adrenergic alpha-Agonists | 1 | 2001 | 31 | 0.010 |
Why?
| | Anaerobic Threshold | 1 | 2001 | 24 | 0.010 |
Why?
| | Mental Status Schedule | 1 | 2001 | 41 | 0.010 |
Why?
| | Pain Management | 1 | 2004 | 315 | 0.010 |
Why?
| | Muscle Contraction | 1 | 2004 | 421 | 0.010 |
Why?
| | Mathematics | 1 | 2001 | 105 | 0.010 |
Why?
| | Cholecystokinin | 1 | 2000 | 15 | 0.010 |
Why?
| | Menstrual Cycle | 1 | 2001 | 115 | 0.010 |
Why?
| | Energy Metabolism | 1 | 2006 | 786 | 0.010 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2000 | 79 | 0.010 |
Why?
| | Mice, Inbred DBA | 1 | 2000 | 185 | 0.010 |
Why?
| | Dimerization | 1 | 2000 | 181 | 0.010 |
Why?
| | Listeriosis | 1 | 2000 | 60 | 0.010 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2000 | 148 | 0.010 |
Why?
| | Ovary | 1 | 2001 | 205 | 0.010 |
Why?
| | Allergens | 1 | 2003 | 430 | 0.010 |
Why?
| | Therapeutic Irrigation | 1 | 2000 | 70 | 0.010 |
Why?
| | Young Adult | 1 | 2015 | 11384 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2008 | 4824 | 0.010 |
Why?
| | Oxygen Consumption | 1 | 2001 | 620 | 0.010 |
Why?
| | Cerebellum | 1 | 2000 | 244 | 0.010 |
Why?
| | Glossopharyngeal Nerve | 1 | 1998 | 11 | 0.010 |
Why?
| | Rats, Long-Evans | 1 | 1998 | 104 | 0.010 |
Why?
| | Afferent Pathways | 1 | 1998 | 44 | 0.010 |
Why?
| | Nodose Ganglion | 1 | 1997 | 6 | 0.010 |
Why?
| | Cerebral Cortex | 1 | 2000 | 450 | 0.010 |
Why?
| | Amnesia, Retrograde | 1 | 1996 | 3 | 0.010 |
Why?
| | Appetitive Behavior | 1 | 1996 | 8 | 0.010 |
Why?
| | Neoplasms | 1 | 2011 | 2340 | 0.010 |
Why?
| | Sodium Azide | 1 | 1996 | 6 | 0.010 |
Why?
| | Synaptic Membranes | 1 | 1996 | 19 | 0.010 |
Why?
| | Infusions, Parenteral | 1 | 1996 | 39 | 0.010 |
Why?
| | Zymosan | 1 | 1996 | 64 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2003 | 3326 | 0.010 |
Why?
| | Space Perception | 1 | 1996 | 66 | 0.010 |
Why?
| | Chlorisondamine | 1 | 1994 | 4 | 0.010 |
Why?
| | Adrenal Medulla | 1 | 1994 | 7 | 0.010 |
Why?
| | Acute Disease | 1 | 1998 | 1016 | 0.010 |
Why?
| | Child | 1 | 1993 | 20014 | 0.010 |
Why?
| | Skin Temperature | 1 | 1993 | 17 | 0.010 |
Why?
| | Binding Sites | 1 | 1996 | 1248 | 0.010 |
Why?
| | Pyramidal Tracts | 1 | 1992 | 22 | 0.010 |
Why?
| | Cold Temperature | 1 | 1993 | 139 | 0.010 |
Why?
| | Mitochondria | 1 | 1996 | 823 | 0.010 |
Why?
| | Regression Analysis | 1 | 1992 | 1047 | 0.010 |
Why?
| | Immunoglobulin gamma-Chains | 1 | 1988 | 3 | 0.000 |
Why?
|
|
Fleshner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|